
Warning: Constant ABSPATH already defined in D:\www\www164\blog\wp-config.php on line 31
{"id":164,"date":"2015-01-24T00:57:51","date_gmt":"2015-01-23T22:57:51","guid":{"rendered":"https:\/\/www.protpi.ch\/blog\/?p=164"},"modified":"2021-03-15T17:26:32","modified_gmt":"2021-03-15T15:26:32","slug":"prediction-of-potential-modification-sites-in-proteins","status":"publish","type":"post","link":"https:\/\/www.protpi.ch\/blog\/bioinformatics\/2015\/01\/prediction-of-potential-modification-sites-in-proteins\/","title":{"rendered":"Prediction of potential modification sites in proteins"},"content":{"rendered":"<p>Some sequence motifs in proteins tend to be modified. Thus, for example an N-terminal glutamine or glutamic acid residue can spontaneously lead to a cyclization. This reaction results in an N-terminal <a title=\"Formation of Pyroglutamic Acid from N-Terminal Glutamic Acid in Immunoglobulin Gamma Antibodies\" href=\"http:\/\/pubs.acs.org\/doi\/abs\/10.1021\/ac051827k\" target=\"_blank\" rel=\"noopener\">pyroglutamic acid<\/a> with elimination of ammonia or water, respectively.\u00a0Aspartyl and asparaginyl <a title=\"Deamidation, Isomerization, and Racemization at Asparaginyl and Aspartyl Residues in Peptides\" href=\"http:\/\/www.jbc.org\/content\/262\/2\/785.long\" target=\"_blank\" rel=\"noopener\">deamidation, isomerization, and racemization<\/a> reactions can spontaneously occur, if the subsequent amino acid is glycine.\u00a0This could alter the protein structure and thereby <a title=\"Isomerization of an Aspartic Acid Residue in the Complementarity-Determining Regions of a Recombinant Antibody to Human IgE:\u2009 Identification and Effect on Binding Affinity\" href=\"http:\/\/pubs.acs.org\/doi\/abs\/10.1021\/bi951526c\" target=\"_blank\" rel=\"noopener\">inhibit the antigen binding affinities<\/a>\u00a0or lead to a <a title=\"Chemical Pathways of Peptide Degradation. IV. Pathways, Kinetics, and Mechanism of Degradation of an Aspartyl Residue in a Model Hexapeptide\" href=\"http:\/\/link.springer.com\/article\/10.1023%2FA%3A1018981231468\" target=\"_blank\" rel=\"noopener\">backbone hydrolysis<\/a>. In eukaryotic cells, NXS\/T motifs are predominately <a title=\"Sequence differences between glycosylated and non-glycosylated Asn-X-Thr\/Ser acceptor sites: implications for protein engineering\" href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2349213\/\" target=\"_blank\" rel=\"noopener\">glycosylated<\/a>,\u00a0where X denotes any amino acid except proline.\u00a0All <a title=\"Alignment of alleles: human (Homo sapiens) IGHC\" href=\"http:\/\/www.imgt.org\/IMGTrepertoire\/Proteins\/alleles\/list_alleles.php?species=Homo%20sapiens&amp;group=IGHC\" target=\"_blank\" rel=\"noopener\">alleles<\/a>\u00a0and <a title=\"Human IGH C-REGIONs\" href=\"http:\/\/www.imgt.org\/IMGTrepertoire\/Proteins\/protein\/human\/IGH\/IGHC\/Hu_IGHCallgenes.html\" target=\"_blank\" rel=\"noopener\">isotypes<\/a>\u00a0of human IgG \u03b3-chains terminates with lysine. In most cases\u00a0these C-terminal lysines were enzymatically <a title=\"Heterogeneity of monoclonal antibodies\" href=\"http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jps.21180\/abstract\" target=\"_blank\" rel=\"noopener\">processed<\/a> by <a title=\"C-terminal lysine variants in fully human monoclonal antibodies: Investigation of test methods and possible causes\" href=\"http:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/bit.21855\/abstract\" target=\"_blank\" rel=\"noopener\">basic carboxypeptidases<\/a>.<!--more--><\/p>\n<p>Al these modifications are triggered by a specific sequence motif. This allows <a title=\"Protein Tool\" href=\"https:\/\/www.protpi.ch\/Calculator\/ProteinTool\" target=\"_blank\" rel=\"noopener\">Prot pi\u00a0|\u00a0Protein Tool <\/a>making predictions of potential modifications sites by means of the amino acid sequence. Figure 1 shows the amino acid sequence of the heavy chain of <a title=\"DrugBank\" href=\"http:\/\/www.drugbank.ca\/drugs\/DB00072\" target=\"_blank\" rel=\"noopener\">trastuzumab<\/a>\u00a0(a therapeutic monoclonal antibody) in the results section of a calculation request on <a title=\"Protein Tool\" href=\"https:\/\/www.protpi.ch\/Calculator\/ProteinTool\" target=\"_blank\" rel=\"noopener\">Prot pi\u00a0|\u00a0Protein Tool<\/a>. With the drop-down menu beneath the sequence, modification sites can be selected to be highlighted.\u00a0In my <a title=\"Molecular mass and isoelectric point calculator for glycosylated proteins\" href=\"\/blog\/bioinformatics\/2015\/01\/isoelectric-point-and-molecular-mass-calculator-for-glycosylated-proteins\/\">last post<\/a> you can find a detailed tutorial how to enter the amino acid sequence and run a calculation.<\/p>\n<figure id=\"attachment_165\" aria-describedby=\"caption-attachment-165\" style=\"width: 300px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/www.protpi.ch\/blog\/wp-content\/uploads\/2015\/01\/Predict-Modification-Site.png\"><img loading=\"lazy\" decoding=\"async\" class=\"size-medium wp-image-165\" src=\"https:\/\/www.protpi.ch\/blog\/wp-content\/uploads\/2015\/01\/Predict-Modification-Site-300x243.png\" alt=\"Figure 1: Prediction of potential modification site using Prot pi | Protein Tool.\" width=\"300\" height=\"243\" srcset=\"https:\/\/www.protpi.ch\/blog\/wp-content\/uploads\/2015\/01\/Predict-Modification-Site-300x243.png 300w, https:\/\/www.protpi.ch\/blog\/wp-content\/uploads\/2015\/01\/Predict-Modification-Site-50x41.png 50w, https:\/\/www.protpi.ch\/blog\/wp-content\/uploads\/2015\/01\/Predict-Modification-Site-604x490.png 604w, https:\/\/www.protpi.ch\/blog\/wp-content\/uploads\/2015\/01\/Predict-Modification-Site-302x245.png 302w, https:\/\/www.protpi.ch\/blog\/wp-content\/uploads\/2015\/01\/Predict-Modification-Site.png 869w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/a><figcaption id=\"caption-attachment-165\" class=\"wp-caption-text\">Figure 1: Prediction of potential modification site using Prot pi | Protein Tool.<\/figcaption><\/figure>\n<p>Trastuzumab has been extensively analyzed by <a title=\"Structural characterization of immunoglobulin G antibodies with LC-MS based approaches\" href=\"http:\/\/hdl.handle.net\/2047\/d20002572\" target=\"_blank\" rel=\"noopener\">Yi Wang<\/a>\u00a0(2012) from Northeastern University using LC-MS based approaches. In this respect it was found that the heavy chain of trastuzumab has undergone all these common chemical modifications.<\/p>\n<span id=\"tablepress-2-description\" class=\"tablepress-table-description tablepress-table-description-id-2\">Table 1: Predicted and measured modifications of the heavy chain of trastuzumab with the percentage of appearence.<\/span>\n\n<table id=\"tablepress-2\" class=\"tablepress tablepress-id-2\" aria-describedby=\"tablepress-2-description\">\n<thead>\n<tr class=\"row-1\">\n\t<th class=\"column-1\">Modification<\/th><th class=\"column-2\">Seq. Loc.<\/th><th class=\"column-3\">Predicted<\/th><th class=\"column-4\">Measured<\/th><th class=\"column-5\">Percentage<\/th>\n<\/tr>\n<\/thead>\n<tbody class=\"row-striping row-hover\">\n<tr class=\"row-2\">\n\t<td class=\"column-1\">Pyroglutamate<\/td><td class=\"column-2\">1 (E)<\/td><td class=\"column-3\">\u2714<\/td><td class=\"column-4\">\u2714<\/td><td class=\"column-5\">1.32 %<\/td>\n<\/tr>\n<tr class=\"row-3\">\n\t<td class=\"column-1\">Deamidation<\/td><td class=\"column-2\">55 (N)<\/td><td class=\"column-3\">\u2714<\/td><td class=\"column-4\">\u2714<\/td><td class=\"column-5\">2.93 %<\/td>\n<\/tr>\n<tr class=\"row-4\">\n\t<td class=\"column-1\">Deamidation<\/td><td class=\"column-2\">84 (N)<\/td><td class=\"column-3\">\u2718<\/td><td class=\"column-4\">\u2714<\/td><td class=\"column-5\">0.19 %<\/td>\n<\/tr>\n<tr class=\"row-5\">\n\t<td class=\"column-1\">Deamidation<\/td><td class=\"column-2\">319 (N)<\/td><td class=\"column-3\">\u2714<\/td><td class=\"column-4\">\u2714<\/td><td class=\"column-5\">1.51 %<\/td>\n<\/tr>\n<tr class=\"row-6\">\n\t<td class=\"column-1\">Deamidation<\/td><td class=\"column-2\">388 (N)<\/td><td class=\"column-3\">\u2714<\/td><td class=\"column-4\">\u2714<\/td><td class=\"column-5\">2.22 %<\/td>\n<\/tr>\n<tr class=\"row-7\">\n\t<td class=\"column-1\">Isomerization<\/td><td class=\"column-2\">102 (D)<\/td><td class=\"column-3\">\u2714<\/td><td class=\"column-4\">\u2714<\/td><td class=\"column-5\">0.61 %<\/td>\n<\/tr>\n<tr class=\"row-8\">\n\t<td class=\"column-1\">Isomerization<\/td><td class=\"column-2\">284 (D)<\/td><td class=\"column-3\">\u2714<\/td><td class=\"column-4\">\u2718<\/td><td class=\"column-5\">n.a.<\/td>\n<\/tr>\n<tr class=\"row-9\">\n\t<td class=\"column-1\">Isomerization<\/td><td class=\"column-2\">405 (D)<\/td><td class=\"column-3\">\u2714<\/td><td class=\"column-4\">\u2714<\/td><td class=\"column-5\">0.92 %<\/td>\n<\/tr>\n<tr class=\"row-10\">\n\t<td class=\"column-1\">N-Glycosylation<\/td><td class=\"column-2\">301 (N)<\/td><td class=\"column-3\">\u2714<\/td><td class=\"column-4\">\u2714<\/td><td class=\"column-5\">100 %<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<!-- #tablepress-2 from cache -->\n<p>The deamidation of asparagine 84 was the only modification which was measured but not predicted. However, the degree of deamidation at this site was only very small 0.19 %. The other way around, the aspartic acid 284 was identified as potential modification site, but no modification was observed. Nevertheless the predicted and the measured modification sites correlate very well. Thus, this is a straightforward feature to find potential modification sites, and hence to focus on the relevant further investigations in the laboratory.<\/p>\n<p>Thank you for your trust in <a title=\"Prot pi\" href=\"https:\/\/www.protpi.ch\/\" target=\"_blank\" rel=\"noopener\">Prot pi<\/a>!<\/p>\n<p>[ratings]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Some sequence motifs in proteins tend to be modified. Thus, for example an N-terminal glutamine or glutamic acid residue can spontaneously lead to a cyclization. This reaction results in an N-terminal pyroglutamic acid with elimination of ammonia or water, respectively.\u00a0Aspartyl and asparaginyl deamidation, isomerization, and racemization reactions can spontaneously occur, if the subsequent amino acid [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[7,20,21],"class_list":["post-164","post","type-post","status-publish","format-standard","hentry","category-bioinformatics","tag-bioinformatics","tag-how-to","tag-modifications"],"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.protpi.ch\/blog\/wp-json\/wp\/v2\/posts\/164","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.protpi.ch\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.protpi.ch\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.protpi.ch\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.protpi.ch\/blog\/wp-json\/wp\/v2\/comments?post=164"}],"version-history":[{"count":7,"href":"https:\/\/www.protpi.ch\/blog\/wp-json\/wp\/v2\/posts\/164\/revisions"}],"predecessor-version":[{"id":546,"href":"https:\/\/www.protpi.ch\/blog\/wp-json\/wp\/v2\/posts\/164\/revisions\/546"}],"wp:attachment":[{"href":"https:\/\/www.protpi.ch\/blog\/wp-json\/wp\/v2\/media?parent=164"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.protpi.ch\/blog\/wp-json\/wp\/v2\/categories?post=164"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.protpi.ch\/blog\/wp-json\/wp\/v2\/tags?post=164"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}